Piperine in food: Interference in the pharmacokinetics of phenytoin

  • T. Velpandian
  • R. Jasuja
  • R. K. Bhardwaj
  • J. Jaiswal
  • S. K. Gupta


This study was carried out to explore the effect of piperine-containing food in altering the pharmacokinetics of phenytoin, an antiepileptic drug with a narrow therapeutic index. A preliminary pharmacokinetic study was carried out in mice by administering phenytoin (10 mg) orally, with or without piperine (0.6 mg). Subsequently, oral pharmacokinetics of phenytoin was carried out in six healthy volunteers in a crossover design. Phenytoin tablet (300 mg) was given 30 minutes after ingestion of a soup (melahu rasam) with or without black pepper. A further study of intavenous pharmacokinetics of phenytoin (1 mg) in rats with or without oral pretreatment with piperine (10 mg) was also conducted. The phenytoin concentration in the serum was analyzed by HPLC. The study showed a significant increase in the kinetic estimates of Ka, AUC(0−10) and AUC(0−∞) in the piperine-fed mice. Similarly, in human volunteers piperine increased Ka, AUC(0−48), AUC(0−∞), and delayed elimination of phenytoin. Intravenous phenytoin in the oral piperine-treated rat group showed a significant alteration in the elimination phase indicating its metabolic blockade. The significance of this finding in epileptic patients maintained on phenytoin therapy requires further investigation. This study may also have implications in the case of other drugs having a low therapeutic index.


Piperine phenytoin food-drug interaction Piper longum 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lewis Y.S. (1997): In the proceedings of third Asian Symposium on Medicinal Plants and Species, Columbo. 139–151.Google Scholar
  2. 2.
    Bose. K.G. (1928): Pharmacopoeia Indica.Google Scholar
  3. 3.
    Atal C.K., Zutshi U., and Rao P.G. (1981): Scientific evidence on the on the role of Ayurvedic herbals on bioavailability of drugs. J. Ethnopharmacol., 4:229–232.PubMedCrossRefGoogle Scholar
  4. 4.
    Zutshi U., and Kaul J.L. (1982): The impact of Ayurvedic herbals on drug bioavailability. Indian Drugs 19:476–479.Google Scholar
  5. 5.
    Zutshi R.K., Singh R., Zutshi U., Johri R.K., and Atal C.K. (1985): Influnce of piperine on rifampicin blood levels in patients of pulmonary tuberclosis J. Ass. Phys. India 33:223–224.Google Scholar
  6. 6.
    Archer A.W. (1986): Separation and determination of piperine in ground pepper by high performance liquid chromatography. J. Chromatogr. 351: 595–598.CrossRefGoogle Scholar
  7. 7.
    Shoba G., Joy D., Joseph T., Majeed M., Ragendran R., and Srinivas P.S. (1998): Influence of piperine on the [pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:53–56.CrossRefGoogle Scholar
  8. 8.
    Bano G., Amla V., Raina R.K., Zytshi U., and Chopra C.L. (1987): The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med. 53:568–569.PubMedCrossRefGoogle Scholar
  9. 9.
    Atal C.K., Dubey R.K., and Singh J. (1985): Biochemical basis of enhanced drug bioavalability by piperine: Evidence that piperine is a potent inhibitor of drug metabolism. J. Pharmacol. Exp. Ther. 232:258–262.PubMedGoogle Scholar
  10. 10.
    Lichtenburger L.M., Romero J.J., Carryl O.R., and Lllich P.A., and Walters E.T. (1998): Effect of pepper and bismuth subsalicylate on gastric pain and surface hydrophobicity in the rat. Aliment. Pharmacol. Ther. 12:483–490.CrossRefGoogle Scholar
  11. 11.
    Khajuria, A., Zutshi, U., and Bendi, K.L. (1998): Permeability characteristics of piperine on oral absorption-an active alkaloid from peppers and a bioavailability enhancer. Ind. J. Exp. Biol. 36:46–50.Google Scholar
  12. 12.
    Bhat. G.B., and Chandrasekaran, N. (1987): Effect of black pepper and piperine on bile secretion and composition in rats. Nahrung 31:913–916.CrossRefGoogle Scholar
  13. 13.
    Martin E., Tozer T.N., Sheiner L.B., and Riegelman S (1977): The clinical pharmacokinetics of phenytoin. J. Pharmacokin. Biopharm. 5:579–596.CrossRefGoogle Scholar
  14. 14.
    Glazko A.J., Peterson F.E., Chang T., Dill W.A., Smith T.C., and Buchanan R.A. (1982): Phenytoin metabolism in subjects with long and short plasma half-lives. Ther. Drug Monit. 4(3):281–292.PubMedCrossRefGoogle Scholar
  15. 15.
    McNamara J.O., (1996): Hardman J.G., Limbird L.E., Molinoff P.B., and Ruddon R.W. (Eds) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill, New York, p. 470Google Scholar
  16. 16.
    Robinson J.D., Morris B.A., Aherne G.W., and Marks V. (1975): Pharmacokinetisof single dose of phenytoin in man measured by radioimmuno assay. Br. J. Clin. Pharmacol. 2:345–349.PubMedGoogle Scholar
  17. 17.
    Ellenhorn M.J., and Barceloux D.G. Medical Toxicology (1998): Diagnosis and Treatment of Hyman Poisoning. Elsevier, New York.Google Scholar

Copyright information

© Springer-Verlag 2001

Authors and Affiliations

  • T. Velpandian
  • R. Jasuja
  • R. K. Bhardwaj
  • J. Jaiswal
  • S. K. Gupta
    • 1
  1. 1.Department of PharmacologyAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations